Company overview
USCC
913307837045812886
Id2
330783000011022
English Name
Zhejiang Haisen Pharmaceutical Co., Ltd.
Former names
东阳市化学制药有限公司, 浙江海森药业有限公司, 东阳市海森药业有限公司
Chinese Name
浙江海森药业股份有限公司
Entity type
Joint Stock Company (Non-Listed, Natural Person Invested or Controlled)
Authorized capital
¥5,100
Phone
+8657986768686
Representative
王式跃
Establishment date
18 February 1998
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 4 December 2020 | PK | 29400000 | Pharmaceutical Allopathic Raw Materialsucralfate Micronized | Highnoon Laboratories Limited | PK | Zhejiang Haisen Pharmaceutical Company Limited | ID | $200,000.00 |
| 5 August 2024 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | $159,600.00 | |
| 12 December 2023 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) Coa Terlampir | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | $137,160.00 | |
| 16 May 2023 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) Coa Terlampir | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | $135,000.00 | |
| 18 July 2018 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) Coa Terlampir | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | CN | $131,600.00 |
| 10 October 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,850.00 | |
| 8 August 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,650.00 | |
| 12 September 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,610.00 | |
| 6 July 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,600.00 | |
| 12 December 2023 | ID | 29400000 | Sucralfate Usp (Micronized) | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,400.00 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Dexa Medica | buyer | $3,084,235 | 33.13% |
| PT Bina San Prima | buyer | $2,375,760 | 25.52% |
| PT Wolong Soko Indonesia | buyer | $468,454 | 5.03% |
| PT Ferron Par Pharmaceuticals | buyer | $446,838 | 4.80% |
| PT Satya Samitra Niagatama | buyer | $407,000 | 4.37% |
| PT Sanbe Farma | buyer | $405,400 | 4.35% |
| PT Global Chemindo Megatrading | buyer | $324,626 | 3.49% |
| Wockhardt Limited | buyer | $98,000 | 1.05% |